Baldness, Benign Prostate Hyperplasia, Prostate Cancer, and Androgen Levels
January 2008
in “
The Aging Male
”
Studysummary This study found no difference in male pattern baldness between patients with benign prostate hyperplasia and prostate cancer, and no correlation with serum androgen levels.
Our plain-language summary. Not medical advice or a treatment recommendation. Consult a qualified healthcare professional before changing treatment. Full disclaimer
In the 2008 study involving 152 patients, with 108 diagnosed with benign prostate hyperplasia (BPH) and 44 with prostate cancer, researchers investigated the relationship between baldness patterns, specifically androgenic alopecia (AA), and serum androgen levels. They utilized Norwood's classification to categorize baldness into vertex and frontal types and measured serum total, free, and bioavailable testosterone, among other hormones. The study concluded that there was no significant difference in the prevalence of AA between the BPH and prostate cancer groups, nor was there a correlation between AA and serum androgen levels in either group. The researchers suggested the need for larger-scale studies to further explore the potential connections between BPH, prostate cancer, and AA.